期刊文献+

肾动脉狭窄患者肾动脉支架置入术后再狭窄及肾功能和血压的改变 被引量:5

Evaluation of restenosis,renal function and blood pressure after the renal artery stenting in patients with atherosclerosis renovascular disease
原文传递
导出
摘要 目的评估肾动脉支架术后再狭窄的发生及肾功能及血压的改变。方法对135 例单侧或双侧肾动脉明显狭窄(管腔内径减少≥70%)的患者行肾动脉支架置入术(PTRAS),术后行肾动脉造影、血压及血肌酐(Scr)的随访观察。结果 135例患者植入147枚支架均获成功。术后肾动脉造影随访率70%,平均随访时间为(7.2±5.6)月,再狭窄率为7.4%。血压及肾功能随访率为95%,平均随访时间(22±6)月,随访患者的收缩压与舒张压均明显下降,分别为 [(172±23)比(159±20)mm Hg,P<0.05,(93±16)比(85±13)mm Hg,P<0.05]。但术后12个月及24个月Scr和GFR与术前比较无显著性差异。结论肾动脉支架置入术后的再狭窄率较低,PTRAS有助于患者的血压控制。 Objective To evaluate the restenosis, renal function and blood pressure after renal artery stenting in patients with atherosclerosis renovascular disease. Methods Percutaneous renal artery stont (PTRAS) was performed in 135 patients with single or bilateral renal artery stenosis (≥70%).Clinical data of above patients were studied during follow-up period. Results A total of 147 stents were successfully deployed in 145 lesions of 135 consecutive patients. Seventy percent of the patients were followed-up by renal artery angiography for an average of (7.2±5.6) months. The restenosis rate of the renal artery was 7.4%. Ninety-five percent of patients were followed-up for blood pressure and renal function for an average of (22±6)months. The systolic and diastolic pressure were significantly decreased from 172±23/93±16 mm Hg to 159±20/85±13 mm Hg(P 〈 0.05). The serum creatifine level and glomerular filtration rate (GFR) did not change significantly during 12 months and 24 months follow-up. Conclusions Implantation of renal artery stent benefits the improvement of blood pressure in the patients with atherosclerosis renal vascular disease with a low renal artery restenosis rate.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2006年第6期332-335,共4页 Chinese Journal of Nephrology
关键词 动脉硬化 肾动脉梗阻 血压 支架 再狭窄 Arteriosclerosis Renal artery obstruction Blood pressure Stent Restenosis
  • 相关文献

参考文献18

  • 1Textor SC. Atherosclerotic renovascular disease as a cause of end-stage renal disease: cost considerations. Blood Purif,1996, 14:305-314.
  • 2Leertouwer TC, Gussenhoven EJ, Bosch JL, et al. Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology, 2000, 216:78-85.
  • 3Olin JW. Atherosclerotic renovascular disease: diagnosis and management. Curr Opin Cardiol, 1990, 5:659-665.
  • 4Rundback JH, Sacks D, Kent KC, et al. Guidelines for the reporting of renal artery revascularization in clinical trials.American Heart Association. Circulation, 2002, 106:1572-1585.
  • 5Morganti A, Bencini C, Del Vecchio C, et al. Treatment of atherosclerotic renal artery stenosis. J Am Soc Nephrol,2002, 13 Suppl 3:S187-S189.
  • 6United States Renal Data System (USRDS) 1997 Annual Data Report. Bethesda, Maryland, US Department of Health and Human Services/National Institute of Health/National Institute of Diabetes and Digestive and Kidney Diseases,1997.
  • 7van de Ven PJ, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet, 1999, 353(9149):282-286.
  • 8Isles CG, Robertson S, Hill D. Management of renovascular disease: a review of renal artery stenting in ten studies.QJM, 1999, 92:159-167.
  • 9Henry M, Amor M, Henry I, et al. Stent placement in the renal artery: three-year experience with the palmaz stent. J Vasc Interv Radiol, 1996, 7 : 343-350.
  • 10Zeller T, Frank U, Muller C, et al. Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation,2003, 108 : 2244-2249.

二级参考文献9

  • 1Buller CE, Nogareda JG, Ramanathan K, et al. The profile of cardiac patients with renal artery stenosis. J Am coll Cardiol, 2004, 43, 1606-1613.
  • 2Rundback JH, Sacks D, Kent KC, et al. Guidelines for the reporting of renal artery revascularization in clinical trials. Circulation, 2002, 106: 1572-1585.
  • 3Leetouwer TC, Gussenhoven EJ, van Jaarsveld BC, et al. Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology, 2000, 216:78-85.
  • 4Chade AR, Lerman A, Lerman LO, et al. Kidney in early atherosclerosis. Hypertension, 2005, 45:1042-1049.
  • 5Zeller T, Frank U, Muller C, et al. Stent-supported angioplasty severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control: long-term results from a prospective registry of 456 lesions. J Endovas Ther, 2004, 11:95-106.
  • 6Zeller T, Frank U, Muller F, et al. Predictor of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation, 2003, 108:2244-2249.
  • 7Kanwar SG, Richard CF. Atherosclerotic renal arterial stenosis: clinical outcomes of stent placement for hypertension and renal failure. Radiology, 2003, 226: 821-826.
  • 8倪钧,沈卫峰,张瑞岩,张奇,张宪,郑爱芳.血清肌酐异常病人肾动脉介入治疗的疗效及安全性[J].中国介入心脏病学杂志,2003,11(6):290-292. 被引量:2
  • 9倪钧,沈卫峰,张瑞岩,胡健,张奇,谢静远.冠心病患者肾动脉介入治疗后尿微球蛋白的变化[J].中华内科杂志,2004,43(1):22-25. 被引量:8

共引文献2

同被引文献55

引证文献5

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部